483 related articles for article (PubMed ID: 9377959)
1. Cross regulation by IL-10 and IL-2/IL-12 of the helper T cells and the cytolytic activity of lymphocytes from malignant effusions of lung cancer patients.
Chen YM; Yang WK; Ting CC; Tsai WY; Yang DM; Whang-Peng J; Perng RP
Chest; 1997 Oct; 112(4):960-6. PubMed ID: 9377959
[TBL] [Abstract][Full Text] [Related]
2. Restoration of the immunocompetence by IL-2 activation and TCR-CD3 engagement of the in vivo anergized tumor-specific CTL from lung cancer patients.
Chen YM; Yang WK; Whang-Peng J; Tsai WY; Hung YM; Yang DM; Lin WC; Perng RP; Ting CC
J Immunother; 1997 Sep; 20(5):354-64. PubMed ID: 9336742
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-7 and interleukin-12 have different effects in rescue of depressed cellular immunity: comparison of malignant and tuberculous pleural effusions.
Chen YM; Tsai CM; Whang-Peng J; Perng RP
J Interferon Cytokine Res; 2001 Apr; 21(4):249-56. PubMed ID: 11359656
[TBL] [Abstract][Full Text] [Related]
4. Restoration of cytotoxic T lymphocyte function in malignant pleural effusion: interleukin-15 vs. interleukin-2.
Chen YM; Ting CC; Peng JW; Yang WK; Yang KY; Tsai CM; Perng RP
J Interferon Cytokine Res; 2000 Jan; 20(1):31-9. PubMed ID: 10670650
[TBL] [Abstract][Full Text] [Related]
5. Additive effect of Interleukin-12 and Interleukin-18 on the T-helper cell pathway of malignant pleural effusion.
Yao NS; Chen YM; Perng RP; Whang-Peng J
Lung; 2002; 180(1):15-24. PubMed ID: 12105753
[TBL] [Abstract][Full Text] [Related]
6. [The cytotoxicity of malignant pleural effusion lymphocytes and LAK cells against autologous tumor cells].
Guo Y; Xing Z
Zhonghua Jie He He Hu Xi Za Zhi; 1995 Apr; 18(2):80-2, 127. PubMed ID: 7553955
[TBL] [Abstract][Full Text] [Related]
7. A large quantity of CD3-/CD19-/CD16- lymphocytes in malignant pleural effusion from a patient with recurrent cholangio cell carcinoma.
Onishi H; Morisaki T; Kuga H; Katano M; Doi F; Uchiyama A; Sugitani A; Wada J; Chijiiwa K; Tanaka M
Immunol Invest; 2002 May; 31(2):121-35. PubMed ID: 12148948
[TBL] [Abstract][Full Text] [Related]
8. T-helper type 1/T-helper type 2 balance in malignant pleural effusions compared to tuberculous pleural effusions.
Okamoto M; Hasegawa Y; Hara T; Hashimoto N; Imaizumi K; Shimokata K; Kawabe T
Chest; 2005 Dec; 128(6):4030-5. PubMed ID: 16354877
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-2 stimulation activates mesothelial cellular functioning against autologous tumor cells.
Chen YM; Hsieh YL; Tsai CM; Perng RP
J Chin Med Assoc; 2004 Jul; 67(7):323-30. PubMed ID: 15510928
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-12 augments cytolytic activity of peripheral blood mononuclear cells against autologous lung cancer cells in combination with IL-2.
Hiraki A; Kiura K; Yamane H; Nogami N; Tabata M; Takigawa N; Ueoka H; Tanimoto M; Harada M
Lung Cancer; 2002 Mar; 35(3):329-33. PubMed ID: 11844609
[TBL] [Abstract][Full Text] [Related]
11. Generation propagation, and targeting of human CD4+ helper/killer T cells induced by anti-CD3 monoclonal antibody plus recombinant IL-2. An efficient strategy for adoptive tumor immunotherapy.
Nishimura T; Nakamura Y; Takeuchi Y; Tokuda Y; Iwasawa M; Kawasaki A; Okumura K; Habu S
J Immunol; 1992 Jan; 148(1):285-91. PubMed ID: 1345787
[TBL] [Abstract][Full Text] [Related]
12. Induction of cytolytic activity of lymphocytes from carcinomatous pleural effusion by IL-2 and autologous tumor cells.
Sairenji M; Yanoma S; Motohashi H; Kobayashi O; Okada K; Okamoto T; Tsukuda M; Umeda M
Biotherapy; 1993; 6(4):283-90. PubMed ID: 8018449
[TBL] [Abstract][Full Text] [Related]
13. Elevation of interleukin-10 levels in malignant pleural effusion.
Chen YM; Yang WK; Whang-Peng J; Kuo BI; Perng RP
Chest; 1996 Aug; 110(2):433-6. PubMed ID: 8697847
[TBL] [Abstract][Full Text] [Related]
14. Lysis of fresh human tumour cells by autologous tumour-associated lymphocytes: two distinct types of autologous tumour killer cells induced by co-culture with autologous tumour.
Uchida A; Moore M
Cancer Immunol Immunother; 1985; 20(1):29-37. PubMed ID: 3877561
[TBL] [Abstract][Full Text] [Related]
15. Lysis of fresh human tumor cells by autologous large granular lymphocytes and T-lymphocytes: two distinct killing activities induced by coculture with autologous tumor.
Uchida A; Moore M
J Natl Cancer Inst; 1984 Dec; 73(6):1285-92. PubMed ID: 6239944
[TBL] [Abstract][Full Text] [Related]
16. Lymphokine-activated killer (LAK) cell activity in tumor-infiltrating lymphocytes from non-small cell lung cancer.
Pisani RJ; Krco CJ; Wold LE; McKean DJ
Am J Clin Pathol; 1989 Oct; 92(4):435-46. PubMed ID: 2552792
[TBL] [Abstract][Full Text] [Related]
17. Generation of lymphokine-activated killer (LAK) cell activity from malignant peritoneal effusions.
Chao TY; Hwang WS; Yeh MY
Proc Natl Sci Counc Repub China B; 1995 Apr; 19(2):92-8. PubMed ID: 7624448
[TBL] [Abstract][Full Text] [Related]
18. A study of the cytotoxicity of malignant pleural effusion lymphocytes and LAK cells against autologous tumor cells.
Guo YS; Xing ZL
Chin Med J (Engl); 1994 Dec; 107(12):903-5. PubMed ID: 7882727
[TBL] [Abstract][Full Text] [Related]
19. Gamma-interferon enhances the cytotoxic activity of interleukin-2-induced peripheral blood lymphocyte (LAK) cells, tumor infiltrating lymphocytes (TIL), and effusion associated lymphocytes.
Papamichail M; Baxevanis CN
J Chemother; 1992 Dec; 4(6):387-93. PubMed ID: 1287141
[TBL] [Abstract][Full Text] [Related]
20. Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells.
Tanaka F; Hashimoto W; Okamura H; Robbins PD; Lotze MT; Tahara H
Cancer Res; 2000 Sep; 60(17):4838-44. PubMed ID: 10987295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
